Volume 8, Issue 2 (Summer 2011)
bloodj 2011, 8(2): 137-142 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kashanchi Langarodi M, Abdolrahim Poorheravi H. Prevalence of HCV among thalassemia patients in Shahid Bahonar Hospital, Karaj. bloodj 2011; 8 (2) :137-142
URL: http://bloodjournal.ir/article-1-488-en.html
URL: http://bloodjournal.ir/article-1-488-en.html
Abstract: (13241 Views)
Prevalence of HCV among thalassemia patients
in Shahid Bahonar Hospital, Karaj
Kashanchi Langarodi M.1, Abdolrahim Poorheravi H.2
1Alborz University of Medical Science and Health Services, Karaj, Iran
2General Physician
Abstract
Background and Objectives
Although recent screening policies have markedly decreased the incidence of HCV infection in transfusion dependent thalassemia paitients, this problem is still one of the most important causes of mortality and morbidity in thalassemic patients.
Materials and Methods
A retrospective cross-sectional study was conducted on 206 thalassemia patients referred to the Shahid Bahonar Hospital during 2009-2010 .Serum specimens were tested with anti –HCV assay and RIBA –II technique to asses HCV infection. Statistical analysis was done with SPSS18 (χ2 and T-test).
Results
The overall prevalence rate of anti-HCV was 15% )11 male, 20 female). Moreover 29 anti-HCV positive patients were RIBA –II positive(11 male, 18 female). All HCV affected patients but one had received their first transfusion before 1996 when HCV screening had became mandatory.
Conclusions
HCV infection rate compared with the general population is higher in multi transfused thalassemia patients. Out of HCV infected thalassemias, 80% are at risk of developing chronic liver diseases and fibrosis thus preventive measures such as blood donor screening for anti-HCV and stringent infection control procedures are crucial steps to be implemented for HCV prevention.
Key words: Hepatitis C, Thalassemia, Hepatitis C Antibodies
Sci J Iran Blood Transfus Org 2011 8(2): 137-142
Received: 26 Oct 2010
Accepted: 7 Feb 2011
Correspondence: Kashanchi Langarodi M., MD. Pediatrician, Alborz University of Medical Science and Health Services, Shahid Bahonar Hospital, Chaloos street.
Postal Code: 3154686695, Karaj, Iran. Tel: (+98261)2500123 Fax: (+98261)2509255
E-mail: Mojgan.kashanchi@yahoo.com
Type of Study: Research |
Subject:
Infectious disease
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
